Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

A Nasal Spray for the Common Cold? [and it's not Zicam]

|Includes: Matrixx Initiatives Inc. (MTXX)
Boehringer Ingelheim locks up a promising OTC nasal spray technology to prevent the common cold --- just what Zicam [Matrixx] needed.  Unfortunately the product roll out appears to be entirely outside the US.  n June 28 Boehringer-Ingelheim announced a licensing deal with Marinomed Biotechnologie GmbH for its anti-viral nasal spray marketed in Austria as Coldamaris™.

Read More

Disclosure: None